3 min
0
Clofutriben Receives FDA Orphan Drug Designation to Treat Endogenous Cushing Syndrome
The randomized, placebo-controlled RESCUE phase 3 trial assessed clofutriben among individuals with ACTH-dependent endogenous Cushing…
